University of Campinas, Brazil clinical trials
University of Campinas, Brazil is the lead sponsor of 10 current clinical trials in our Brazil register. 4 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Dapagliflozin. The most-studied condition is Periodontitis.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by University of Campinas, Brazil
10 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Effects of a Pulmonary and Cardiovascular Rehabilitation Program
NCT06772922 · ClinicalTrials.gov ↗ · Respiratory Muscle Weakness, Quality of Lifte, Dyspnea; Asthmatic
|
Not applicable | Recruiting | 2019-03 | Brazil |
|
Resistant Hypertension An Open, Complicated ("Cum Plicare") or Complex ("Cum Plexus") Syndrome?
NCT06450327 · ClinicalTrials.gov ↗ · Hypertension, Resistant Hypertension
|
Observational | Recruiting | 2024-08 | Brazil |
|
Influence of Zirconia Abutments on Peri-Implant Tissues in Single-Tooth Restorations
NCT07456163 · ClinicalTrials.gov ↗ · Peri-Implant Health, Implant Complication, Prosthesis and Implants
|
Not applicable | Recruiting | 2025-04 | Brazil |
|
Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy
NCT06711185 · ClinicalTrials.gov ↗ · Breast Cancer
Drug: Dapagliflozin |
Phase 3 | Recruiting | 2024-01 | Brazil |
|
Structural and Clinical Predictors of Cognitive Impairment After Surgical Treatment for Ruptured Cerebral Aneurysms
NCT07723131 · ClinicalTrials.gov ↗ · Subarachnoid Aneurysm Hemorrhage, Microsurgery, Cognitive Impairment
|
Observational | Not yet open | 2026-08 | Brazil |
|
Pharmacokinetics of Zoledronic Acid in Patients on Dialysis
NCT07741136 · ClinicalTrials.gov ↗ · Chronic Kidney Disease, Osteoporosis, Dialysis
|
Phase 1 | Not yet open | 2026-08 | Brazil |
|
Assessment of Tooth Mobility After Non-surgical Periodontal Treatment Followed by Tooth Splinting
NCT06929676 · ClinicalTrials.gov ↗ · Periodontal Diseases, Periodontitis
|
Not applicable | By invitation | 2025-04 | Brazil |
|
MIST Versus M-MIST for the Treatment of Intrabony Defects
NCT06058923 · ClinicalTrials.gov ↗ · Periodontitis, Intrabony Periodontal Defect, Periodontitis, Chronic
|
Not applicable | Active, closed | 2023-08 | Brazil |
|
Evaluation of Implantoplasty in the Treatment of Peri-Implantitis.
NCT06884475 · ClinicalTrials.gov ↗ · Peri-Implantitis and Peri-implant Mucositis
|
Not applicable | Active, closed | 2025-04 | Brazil |
|
Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer
NCT05315154 · ClinicalTrials.gov ↗ · Breast Cancer
|
Not applicable | Active, closed | 2019-10 | Brazil |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in University of Campinas, Brazil trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in University of Campinas, Brazil trials
21 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Brazil | 10 | 4 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Periodontitis
Sponsors with the most current trials registered for this condition.
Questions about University of Campinas, Brazil trials
How many clinical trials does University of Campinas, Brazil sponsor?
University of Campinas, Brazil is the lead sponsor of 10 current trials on ClinicalTrials.gov in our Brazil register, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.
Are University of Campinas, Brazil trials recruiting?
Yes. 4 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is University of Campinas, Brazil testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Dapagliflozin (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.